"TGen TD2 provides a broad range of regulatory expertise and services with integrated project management to ensure that client programs run seamlessly into clinical development..."

TGen Drug Development (TD2)
Stephen Gately Ph.D, President & Chief Scientific Officer

view all testimonials

Veterinary Pathology

Study pathologist services for non-GLP and GLP studies including carcinogenicity studies
Peer review pathologist for non-GLP, GLP studies and carcinogenicity studies at the CRO
Safety and risk assessment of novel compounds
Expertise in investigative strategies to study mechanism of disease and toxicity
Interpretation of investigative procedures including immunohistochemistry, electron microscopy and target tissue cross reactivity
Project subject matter expertise
Nonclinical study design and protocol development
Review and interpretation of nonclinical data
Review and integration of scientific literature
Preparation of nonclinical summary regulatory documents
Monitoring CRO studies to ensure compliance to study protocol and standard operating procedures

Services

Veterinary Pathology